Discoveries in basic biology often become transformative tools. Illustrate with the example of light-gated ion channels and suggest lessons for India's R&D funding.

The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel "for their discoveries concerning light-gated ion channels and optogenetics" [1]. A protein from an alga became a switch for brain cells. This shows that curiosity-driven biology can become a transformative tool.

From algal protein to neuroscience tool

• Basic discovery: Hegemann and Nagel found channelrhodopsin, a light-sensitive protein, in a single-celled alga. The work had no medical aim [1].
• Tool conversion: Deisseroth turned it into a light-controlled switch. Neurons that carry it can be turned on or off in a living brain [1].
• Correlation to causation: Older methods only linked brain areas to functions and left a "sketch map" of the brain. Optogenetics tests cause and effect behind memory, feelings and behaviour [2].
• Clinical spillover: In 2021, a blind patient with retinitis pigmentosa partially regained vision. A channelrhodopsin variant (ChrimsonR) was delivered to the eye and used with light goggles [3]. Human therapies are still early-stage.

Algal light-sensing protein → gene placed in neurons → light switches neurons on/off
        → causal brain mapping → early therapies (vision)

Fig: From basic biology to a transformative tool

Lessons for India's R&D funding

• Patient funding for basic science: The ANRF Act, 2023 plans ₹50,000 crore over 2023–28 [4]. A protected share should go to open-ended, investigator-led grants, not only to mission targets.
• Steer private money upstream: Most of ANRF's corpus is expected from non-government sources [4]. Incentives should draw industry and philanthropy towards early-stage science, not only near-market products.
• Interdisciplinary grants: The vision trial needed both gene delivery and engineered goggles [3]. Biologists, engineers and clinicians should be funded jointly.
• Build on existing institutions: The National Brain Research Centre, Manesar is an autonomous DBT institute and a Deemed University dedicated to neuroscience [5]. It could anchor a programme that starts with retinal applications.
• Ethics built in: Genetic modification of neurons needs consent and safety rules designed alongside the funding.

Optogenetics shows that an obscure question in biology can grow into a platform technology. India can turn its own basic research into tools of this kind. To do so, ANRF's resources should be paired with patient, interdisciplinary and ethically grounded funding, in line with SDG 3 (good health) and SDG 9 (innovation).